ABSTRACT
Background: The gut microbiota (GM) has been implicated in neurological disorders, but the relationship with hydrocephalus, especially the underlying mechanistic pathways, is unclear. Using Mendelian randomization (MR), we aim to discover the mediating role of inflammatory factors in the relationship between GM and hydrocephalus. Methods: After removing confounders, univariable and multivariable MR analyses were performed using summary statistics to assess the causal relationships between GM, inflammatory factors (IL-17A and IL-27), and types of hydrocephalus. Meta-analyses were used to reconcile the differences in MR results between different hydrocephalus sources. Finally, mediator MR analyses were applied to determine the mediating effect of inflammatory factors. Various sensitivity analysis methods were employed to ensure the reliability and stability of the results. Results: After correction for P-values, Firmicutes (phylum) (OR, 0.34; 95%CI, 0.17-0.69; P = 2.71E-03, P FDR = 2.44E-02) significantly reduced the risk of obstructive hydrocephalus. The remaining 18 different taxa of GM had potential causal relationships for different types of hydrocephalus. In addition, Firmicutes (phylum) decreased the risk of obstructive hydrocephalus by increasing levels of IL-17A (mediating effect = 21.01%), while Eubacterium ruminantium group (genus) increased the risk of normal-pressure hydrocephalus by decreasing levels of IL-27 (mediating effect = 7.48%). Conclusion: We reveal the connection between GM, inflammatory factors (IL-17A and IL-27), and hydrocephalus, which lays the foundation for unraveling the mechanism between GM and hydrocephalus.
Subject(s)
Gastrointestinal Microbiome , Hydrocephalus , Interleukin-17 , Mendelian Randomization Analysis , Humans , Gastrointestinal Microbiome/immunology , Hydrocephalus/microbiology , Hydrocephalus/etiology , Hydrocephalus/immunology , Inflammation/microbiology , Interleukin-17/genetics , Interleukin-27/geneticsABSTRACT
BACKGROUND: Shunting is an established treatment for hydrocephalus, yet reports on shunt outcomes for nonbacterial infection (NBI) hydrocephalus are limited. Furthermore, comparison of mechanisms and rates of failure for shunted NBI hydrocephalus versus more typical etiologies remains undetermined. METHODS: Patients who underwent shunting for hydrocephalus at 2 centers (1995-2020) were included. Indications for shunting were grouped as "typical" (congenital, posthemorrhagic, normal pressure hydrocephalus, malignancy-related, trauma, and idiopathic) and NBI hydrocephalus (coccidioidomycosis, cryptococcosis, and neurocysticercosis). Rates of shunt malfunction were compared. RESULTS: There were 261 patients shunted for typical hydrocephalus (48.7% male; age = 50.7 ± 21.7) and 93 patients for NBI hydrocephalus (72.0% male; age = 41.8 ± 13.2). For patients with typical hydrocephalus, 29.5% required ≥1 shunt revision, compared with 64.5% with NBI hydrocephalus (P < 1E-5). Of those with malfunction, NBI shunts required more revision operations (median = 3.0; max = 21) than typical shunts (median = 2.0; max = 6; P < 0.05). The censored median time to shunt failure for NBI hydrocephalus was 26.9 months and was not reached for typical etiologies by 180 months. Multivariate analysis showed shunts for NBI hydrocephalus were significantly more likely to fail (hazard ratio = 2.25; 95% confidence interval = 1.58-3.19). A distal pseudocyst was implicated in 30.0% and 2.6% of shunt failures for NBI and typical hydrocephalus, respectively (P < 1E-5). Sixteen (26.7%) NBI shunt failures required revision to lower-resistance systems compared to 6 (7.8%) typical failures (P < 0.05). CONCLUSIONS: Shunts placed for hydrocephalus secondary to nonbacterial infections are complicated by significantly higher rates of malfunction. These patients are prone to develop distal abdominal pseudocysts and often require revision to low-resistance systems.
Subject(s)
Cardiovascular Abnormalities , Coccidioidomycosis , Hydrocephalus, Normal Pressure , Hydrocephalus , Adult , Aged , Cardiovascular Abnormalities/complications , Cardiovascular Abnormalities/surgery , Case-Control Studies , Cerebrospinal Fluid Shunts/adverse effects , Coccidioidomycosis/complications , Female , Humans , Hydrocephalus/microbiology , Hydrocephalus/surgery , Hydrocephalus, Normal Pressure/surgery , Male , Middle Aged , Prostheses and Implants/adverse effects , Reoperation/adverse effects , Retrospective Studies , Ventriculoperitoneal Shunt/adverse effectsABSTRACT
We describe a newborn infant with hydrocephalus and a ventriculoperitoneal shunt infection caused by Brevibacterium casei. Essential for correct diagnosis was rapid species identification by matrix-assisted laser desorption/ionization time-of-flight, after initial report of coryneform bacteria. The patient responded well to vancomycin and rifampicin for 15 days. The shunt was not removed. Repeated cerebrospinal fluid cultures up to 4 months after therapy remained negative.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Brevibacterium/drug effects , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Brevibacterium/pathogenicity , Gram-Positive Bacterial Infections/cerebrospinal fluid , Humans , Hydrocephalus/microbiology , Infant, Newborn , Male , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Treatment Outcome , Ventriculoperitoneal Shunt/adverse effectsABSTRACT
RATIONALE: Group B Streptococcus (GBS) remains a principal pathogen causing neonatal sepsis and meningitis, particularly in premature infants with relatively insufficient immunity. Recurrence may occur uncommonly, largely associated with subclinical mucosal persistence or repetitive exposure to exogenous sources. White matter injury (WMI) including cystic periventricular leukomalacia (PVL) has been associated with intrauterine infection/inflammation, and neonatal infection as a more significant predictor including postnatal sepsis and recurrent infection, even without microbial neuroinvasion. Furthermore, clinical and experimental evidence of WMI by some bacteria other than GBS without central nervous system invasion has been reported. However, there is little evidence of WMI associated with neonatal GBS sepsis in the absence of meningitis in the literature. PATIENT CONCERNS: A newborn at 30+4 weeks' gestation with low birthweight presented with 2 episodes (with a 13-day interval with no antibiotic therapy) of neonatal sepsis culture-proven for GBS with early-onset presentation after clinical chorioamnionitis via vertical GBS transmission and the associated conditions including prematurity-related neonatal immunodeficiency and persistent mucosal GBS carriage after the first antibiotic treatment. The perinatal GBS infection was complicated by progressive WMI presenting with ventriculomegaly and cystic PVL without a definite evidence of meningitis, intraventricular hemorrhage, and documented cerebral hypoxia or hypoperfusion conditions including septic shock. DIAGNOSES: Recurrent group B streptococcal sepsis and cystic PVL with ventriculomegaly. INTERVENTIONS: Two episodes of GBS sepsis were treated with 15-day parenteral antibiotic therapy, respectively. OUTCOMES: Resolution of the recurrent GBS sepsis without further relapses, however, complicated by WMI and subsequent about 6âmonths delay in motor development at 12 months' corrected age. LESSONS: This case suggests WMI associated with GBS bacteremia without central nervous system entry by viable GBS and also shows that in premature infants, intrauterine GBS infection with no interventions may lead to extensive and persistent GBS colonization, early-onset and recurrent GBS disease, and WMI. Postnatal as well as intrauterine infection/inflammation controls with maternal prophylaxis may be pivotal for prevention and limiting the magnitude of neurologic injury.
Subject(s)
Leukomalacia, Periventricular/microbiology , Neonatal Sepsis/microbiology , Pregnancy Complications, Infectious/microbiology , Streptococcal Infections/complications , Streptococcus agalactiae/isolation & purification , Administration, Intravenous , Anti-Bacterial Agents/administration & dosage , Chorioamnionitis/diagnosis , Chorioamnionitis/microbiology , Developmental Disabilities/diagnosis , Developmental Disabilities/microbiology , Drug Therapy, Combination/methods , Female , Humans , Hydrocephalus/diagnosis , Hydrocephalus/microbiology , Infant , Infant, Low Birth Weight , Infant, Newborn , Infant, Premature , Infectious Disease Transmission, Vertical , Leukomalacia, Periventricular/diagnosis , Leukomalacia, Periventricular/pathology , Magnetic Resonance Imaging , Male , Maternal Age , Neonatal Sepsis/diagnosis , Neonatal Sepsis/therapy , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Recurrence , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Streptococcal Infections/transmission , White Matter/diagnostic imaging , White Matter/microbiology , White Matter/pathology , Young AdultABSTRACT
An HIV-positive mother infected her daughter with extensively drug-resistant Mycobacterium tuberculosis. Despite adhering to the then current guidelines for prevention, the infant was diagnosed with extensively drug-resistant pulmonary tuberculosis at the age of 4 months and developed tuberculous meningitis. After a short delay, appropriate treatment was initiated, followed by an inhospital stay at a specialised hospital. The infant became generally well, but had delayed neurological development. Secondary hydrocephalus due to tuberculous meningitis required a ventriculoperitoneal shunt. After 2 years of microbiologically and clinically effective tuberculosis treatment and several shunt complications, the HIV-negative child died at the age of 28 months â with radiological signs of a shunt infection. The reason for the fatal outcome was probably related to inadequate risk reduction of airborne mother-to-child transmission, inappropriate chemoprophylaxis and delayed initiation of adequate treatment.
Subject(s)
Antitubercular Agents/therapeutic use , Extensively Drug-Resistant Tuberculosis/drug therapy , Extensively Drug-Resistant Tuberculosis/transmission , Infectious Disease Transmission, Vertical , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/transmission , Adult , Antitubercular Agents/pharmacology , Fatal Outcome , Female , Humans , Hydrocephalus/microbiology , Infant , Infant, Newborn , Mycobacterium tuberculosis/drug effects , Tuberculosis, Meningeal/microbiology , Tuberculosis, Pulmonary/complicationsABSTRACT
BACKGROUND: Listeria monocytogenes is a Gram-positive bacteria transmitted to human by animal stools, contaminated water and food. In children, Listeria monocytogenes typically affects newborns and immunocompromised patients often leading to invasive syndromes including sepsis, brain abscesses, meningitis, meningoencephalitis and rhombencephalitis. In healthy and immunocompetent children, Listeria meningitis is rare, but can progress rapidly and may be associated with severe complications (hydrocephalus, ventriculitis, cranial nerves palsy and cerebrospinal abscesses) and high mortality rate. CASE PRESENTATION: We describe a very uncommon case of meningoencephalitis due to Listeria monocytogenes in a 11-month-old immunocompetent girl. Cerebrospinal fluid (CSF) culture was positive on the second day. Antibiotic therapy was promptly started but the disease was complicated by neurological deterioration and decompensated hydrocephalus. The child required a very demanding pediatric and neurosurgical management and was discharged after 40 days without major sequelae. CONCLUSION: Listeria is difficult to isolate and it is not susceptible to first-line treatment for bacterial meningitis with extended-spectrum cephalosporins. Early recognition is therefore crucial for a positive outcome. Pediatricians have to perform close clinical monitoring of these children and be aware of possible complications. A review of all cases of Listeria meningitis complicated by hydrocephalus in healthy children has been performed, to provide an overview on clinical features, treatment options and outcome.
Subject(s)
Hydrocephalus/microbiology , Meningitis, Listeria/complications , Meningitis, Listeria/diagnosis , Female , Humans , Hydrocephalus/diagnosis , Hydrocephalus/therapy , Infant , Meningitis, Listeria/therapyABSTRACT
OBJECTIVE: Coccidioidomycosis is a fungal infection endemic to the southwestern United States. Hydrocephalus can develop after intracranial dissemination, and management of this disease entity is difficult. We present our institutional experience with shunting coccidioidomycosis-related hydrocephalus. METHODS: A cohort of patients with coccidioidomycosis-related hydrocephalus undergoing an intracranial shunt placement were retrospectively identified over a 24-year period. Demographics and treatment characteristics were obtained from the electronic medical record. RESULTS: Thirty patients undergoing 83 procedures were identified, with a median follow-up of 19.4 months. The average age of the cohort was 43 years at the time of initial shunt placement. Most patients (66.7%) had ≥1 shunt failure, and the average number of revisions required was 2.6 for patients who had shunt failure. The average shunt valve pressure threshold required was 5.5 cm H2O, and patients who harbored the disease for a longer period (>7 months) had a lower pressure setting for initial shunt valves. Shunts without an antisiphon component were more likely to be failure free on multivariate analysis (odds ratio, 9.2; 95% confidence interval, 2.4-35.7). Death was associated with a longer diagnosis-to-shunt time interval, and patients having been diagnosed with intracranial disease for more than 10 months before shunt placement had significantly higher rates of death on follow-up. CONCLUSIONS: Patients with coccidioidomycosis-related hydrocephalus typically have normal to low pressure setting requirements, high shunt failure rates, prolonged hospitalizations, and mortality. In this disease context, shunt valves without an antisiphon component are associated with lower shunt failure rates.
Subject(s)
Coccidioidomycosis/complications , Hydrocephalus/microbiology , Hydrocephalus/surgery , Ventriculoperitoneal Shunt , Adult , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Retrospective Studies , Treatment OutcomeSubject(s)
Encephalitis/etiology , Hydrocephalus/etiology , Listeriosis/pathology , Rhombencephalon , Brain/diagnostic imaging , Brain/microbiology , Brain/pathology , Encephalitis/diagnostic imaging , Encephalitis/microbiology , Encephalitis/pathology , Humans , Hydrocephalus/diagnostic imaging , Hydrocephalus/microbiology , Hydrocephalus/pathology , Immunocompromised Host , Listeriosis/complications , Listeriosis/diagnostic imaging , Magnetic Resonance Imaging , Male , Middle Aged , Neuroimaging , Rhombencephalon/diagnostic imaging , Rhombencephalon/microbiology , Rhombencephalon/pathologyABSTRACT
Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis. Although primarily a disease of the respiratory system it may be found in any organ or tissue. Global population movements and the emergence of resistant strains are contributing to increasing numbers of cases in certain populations. Subtlety of symptoms and signs, chronicity of disease and failure to seek medical assistance may result in the diagnosis only being made at the time of autopsy. For this reason forensic pathologists need to understand the protean manifestations of the disease and the variable mechanisms by which TB may cause death. This atlas overview provides descriptions of the pathological manifestations of TB in a variety of organs with accompanying illustrations. It serves as a summary of conditions that should be checked for at autopsy in suspected or confirmed cases.
Subject(s)
Tuberculosis/pathology , Autopsy , Brain/microbiology , Brain/pathology , Disease Transmission, Infectious/prevention & control , Empyema, Tuberculous/pathology , Epididymitis/microbiology , Epididymitis/pathology , Forensic Pathology , Granuloma/pathology , Humans , Hydrocephalus/microbiology , Hydrocephalus/pathology , Infection Control , Kidney/microbiology , Kidney/pathology , Knee/microbiology , Knee/pathology , Lung/pathology , Lymph Nodes/microbiology , Lymph Nodes/pathology , Male , Meninges/microbiology , Meninges/pathology , Microscopy , Mycobacterium tuberculosis/pathogenicity , Necrosis/pathology , Spine/microbiology , Spine/pathology , Trachea/microbiology , Trachea/pathologyABSTRACT
Twenty-seven previously healthy (of 36 consecutive eligible patients), HIV-negative cryptococcal meningoencephalitis (CM) patients underwent comprehensive neuropsychological evaluation during the late post-treatment period (1.3-4 years post diagnosis), assessing attention, language, learning, memory, visuospatial, executive function, information processing, psychomotor functioning, as well as mood symptoms. Seven of eight domains (all except attention) showed increased percentages of CM patients scoring in the less than 16th percentile range compared to standardized normative test averages, adjusted for education level and age. Comparison with a matched archival dataset of mild cognitive impairment/Alzheimer's disease patients showed that CM patients exhibited relative deficits in psychomotor and executive function with fewer deficits in memory and learning, consistent with a frontal-subcortical syndrome. MRI evaluation at the time of testing demonstrated an association of lower neuropsychological functioning with ventriculomegaly. These studies suggest that CM should be included in the list of treatable causes of dementia in neurological work ups. Future studies are needed to identify diagnostic and treatment regimens that may enhance neurological function after therapy.
Subject(s)
Cognition Disorders/diagnosis , Cryptococcus neoformans/isolation & purification , Frontal Lobe/physiopathology , Meningitis, Cryptococcal/complications , Meningoencephalitis/complications , Adult , Aged , Aged, 80 and over , Alzheimer Disease/complications , Alzheimer Disease/physiopathology , Antifungal Agents/therapeutic use , Cognition Disorders/etiology , Cognition Disorders/physiopathology , Datasets as Topic , Executive Function/physiology , Female , Frontal Lobe/diagnostic imaging , Gliosis/diagnosis , Gliosis/microbiology , Gliosis/physiopathology , HIV-1/isolation & purification , Humans , Hydrocephalus/diagnosis , Hydrocephalus/microbiology , Hydrocephalus/physiopathology , Magnetic Resonance Imaging , Male , Meningitis, Cryptococcal/drug therapy , Meningitis, Cryptococcal/microbiology , Meningitis, Cryptococcal/physiopathology , Meningoencephalitis/drug therapy , Meningoencephalitis/microbiology , Meningoencephalitis/physiopathology , Middle Aged , Neuropsychological Tests/statistics & numerical data , Syndrome , Young AdultABSTRACT
Nowadays severe illness in neonates is fortunately rare in Norway. However, newborns present with non-specific symptoms, making diagnostics in this age group challenging, and neonatologists need to think broadly in order not to overlook serious illness. We present the case of a nine-day-old who was severely ill when she arrived at hospital. She was born in gestational week 37 after a normal pregnancy. The birth was complicated by shoulder dystocia, rupture of the umbilical cord and fracture of the clavicle. Thereafter she had a normal stay in the maternity ward for three days. At home she appeared healthy and gained weight until she returned to hospital after thirteen hours of poor feeding, irritability and fever. The symptoms turned out to be caused by bacterial meningitis. During the first week of hospitalisation she developed ventriculitis, brain abscesses and sinus vein thrombosis. It was later discovered that she had severely impaired hearing, and thereafter she developed hydrocephalus requiring surgical drainage. The mortality from neonatal bacterial meningitis has dropped from almost 50 % in the 1970s to less than 10 % today, but the morbidity has remained unchanged. It is crucial that clinicians are alert to this diagnosis, as delayed treatment can worsen the prognosis.
Subject(s)
Meningitis, Escherichia coli , Brain Abscess/microbiology , Cerebral Ventriculitis/microbiology , Escherichia coli/isolation & purification , Female , Fever/microbiology , Humans , Hydrocephalus/microbiology , Infant, Newborn , Magnetic Resonance Imaging , Meningitis, Escherichia coli/complications , Meningitis, Escherichia coli/diagnosis , Meningitis, Escherichia coli/drug therapy , Sinus Thrombosis, Intracranial/microbiologyABSTRACT
BACKGROUND: Ventriculoperitoneal (VP) shunting in cryptococcal meningitis (CM) patients with high intracranial pressure (ICP) has been studied extensively. METHODS: A total of 74 CM patients with ICP were identified, including 27 patients with or without ventriculomegaly receiving VP shunting. RESULTS: Through retrospective analysis, there was an obvious decline in ICP as well as Cryptococcus count after VP shunting. Damage to the cranial nerves was improved after the surgery. For those patients receiving VP shunting, there was an obvious decline in ICP as well as Cryptococcus count, with less usage of mannitol. Hydrocephalus or ventriculomegaly was improved, and both the clearance time of Cryptococcus and the hospitalization time were shortened (p<0.05). The complications of VP shunting were not common. CONCLUSIONS: For patients diagnosed with CM and with apparent ICP, VP shunting can be considered regardless of whether there is damage to the cranial nerves or hydrocephaly.
Subject(s)
Intracranial Hypertension/surgery , Meningitis, Cryptococcal/surgery , Adult , Cryptococcus/genetics , Cryptococcus/isolation & purification , Cryptococcus/physiology , Female , Hospitalization , Humans , Hydrocephalus/microbiology , Hydrocephalus/surgery , Intracranial Hypertension/microbiology , Intracranial Hypertension/physiopathology , Intracranial Pressure , Male , Meningitis, Cryptococcal/microbiology , Meningitis, Cryptococcal/physiopathology , Middle Aged , Retrospective Studies , Ventriculoperitoneal ShuntABSTRACT
Neurologic complications after solid-organ transplant reveal a great spectrum of pathologies. Intracranial hemorrhages, cerebral ischemic lesions, infarctions, lymphoproliferative disorders, and infections, including aspergillosis, have been observed after liver transplant. Fungi constitute nearly 5% of all central nervous system infections, mainly occurring in immunocompromised patients. The most common causative agent is Aspergillus species. It presents either as maxillary sinusitis or pulmonary infection. Brain involvement of Aspergillus carries a high rate of mortality. Aspergillosis presents in the forms of meningitis, mycotic aneurysms, infarctions, and mass lesions. Aspergillosis does not have a specific radiologic appearance. Parenchymal aspergillosis has heterogenous signal intensity (hypointense on T1-weighted and hyperintense on T2-weighted images). Here, we present 3 patients who underwent solid-organ transplant and developed central nervous system aspergillosis. Different modalities of neurosurgical intervention were performed in combination with chemotherapy as part of their fungal therapy.
Subject(s)
Brain Abscess/microbiology , Hydrocephalus/microbiology , Kidney Transplantation/adverse effects , Liver Transplantation/adverse effects , Neuroaspergillosis/microbiology , Opportunistic Infections/microbiology , Adult , Antifungal Agents/therapeutic use , Brain Abscess/diagnostic imaging , Brain Abscess/drug therapy , Brain Abscess/immunology , Female , Humans , Hydrocephalus/diagnostic imaging , Hydrocephalus/drug therapy , Hydrocephalus/immunology , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Magnetic Resonance Imaging , Male , Middle Aged , Neuroaspergillosis/diagnostic imaging , Neuroaspergillosis/drug therapy , Neuroaspergillosis/immunology , Opportunistic Infections/diagnostic imaging , Opportunistic Infections/drug therapy , Opportunistic Infections/immunology , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Communicating hydrocephalus may complicate infantile bacterial meningitis, typically presenting with systemic features of infection. We report a rare case of 'subclinical meningoventriculitis' causing obstructive hydrocephalus and its challenging management. A healthy 10-week-old immunocompetent male patient presented with failure to thrive and vomiting, secondary to presumed gastro-oesophageal reflux. The child was neurologically alert, afebrile with normal inflammatory markers. Progressive macrocephaly prompted an MRI confirming triventricular hydrocephalus secondary to aqueductal stenosis. An endoscopic third ventriculostomy was performed however abandoned intraoperatively due to the unexpected finding of intraventricular purulent cerebrospinal fluid. A 6-week course of intravenous ceftriaxone was commenced for Escherichia coli meningoventriculitis. However, the child was readmitted 18 days postoperatively with acute hydrocephalus requiring a ventricular washout and staged ventriculoperitoneal shunt insertion at 4 weeks. Serial head circumference measurements are paramount in the assessment of a paediatric patient. In an immunocompetent child, a subclinical fibropurulent meningoventriculitis can result in several management challenges.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Cerebral Ventriculitis/microbiology , Hydrocephalus/microbiology , Meningoencephalitis/microbiology , Polytetrafluoroethylene/therapeutic use , Urinary Tract Infections/therapy , Amoxicillin/therapeutic use , Cerebral Ventriculitis/complications , Cerebral Ventriculitis/therapy , Cerebrospinal Fluid Shunts , Humans , Hydrocephalus/etiology , Hydrocephalus/therapy , Infant, Newborn , Injections , Male , Meningoencephalitis/complications , Meningoencephalitis/therapy , Treatment Outcome , Ureter , VentriculostomyABSTRACT
Background: Tuberculous meningitis (TBM) leads to death or disability in half the affected individuals. Tools to assess severity and predict outcome are lacking. Neurospecific biomarkers could serve as markers of the severity and evolution of brain injury, but have not been widely explored in TBM. We examined biomarkers of neurological injury (neuromarkers) and inflammation in pediatric TBM and their association with outcome. Methods: Blood and cerebrospinal fluid (CSF) of children with TBM and hydrocephalus taken on admission and over 3 weeks were analyzed for the neuromarkers S100B, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), in addition to multiple inflammatory markers. Results were compared with 2 control groups: patients with (1) a fatty filum (abnormal filum terminale of the spinal cord); and (2) pulmonary tuberculosis (PTB). Imaging was conducted on admission and at 3 weeks. Outcome was assessed at 6 months. Results: Data were collected from 44 patients with TBM (cases; median age, 3.3 [min-max 0.3-13.1] years), 11 fatty filum controls (median age, 2.8 [min-max 0.8-8] years) and 9 PTB controls (median age, 3.7 [min-max 1.3-11.8] years). Seven cases (16%) died and 16 (36%) had disabilities. Neuromarkers and inflammatory markers were elevated in CSF on admission and for up to 3 weeks, but not in serum. Initial and highest concentrations in week 1 of S100B and NSE were associated with poor outcome, as were highest concentration overall and an increasing profile over time in S100B, NSE, and GFAP. Combined neuromarker concentrations increased over time in patients who died, whereas inflammatory markers decreased. Cerebral infarcts were associated with highest overall neuromarker concentrations and an increasing profile over time. Tuberculomas were associated with elevated interleukin (IL) 12p40, interferon-inducible protein 10, and monocyte chemoattractant protein 1 concentrations, whereas infarcts were associated with elevated tumor necrosis factor α, macrophage inflammatory protein 1α, IL-6, and IL-8. Conclusions: CSF neuromarkers are promising biomarkers of injury severity and are predictive of mortality. An increasing trend suggested ongoing brain injury, even though markers of inflammation declined with treatment. These findings could offer novel insight into the pathophysiology of TBM.
Subject(s)
Biomarkers , Cerebral Infarction , Hydrocephalus , Inflammation , Tuberculosis, Meningeal , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Cerebral Infarction/blood , Cerebral Infarction/cerebrospinal fluid , Cerebral Infarction/microbiology , Child, Preschool , Female , Glial Fibrillary Acidic Protein/blood , Glial Fibrillary Acidic Protein/cerebrospinal fluid , Humans , Hydrocephalus/blood , Hydrocephalus/cerebrospinal fluid , Hydrocephalus/microbiology , Infant , Infant, Newborn , Inflammation/blood , Inflammation/cerebrospinal fluid , Inflammation/microbiology , Male , Phosphopyruvate Hydratase/blood , Phosphopyruvate Hydratase/cerebrospinal fluid , Prospective Studies , S100 Calcium Binding Protein beta Subunit/blood , S100 Calcium Binding Protein beta Subunit/cerebrospinal fluid , Tuberculosis, Meningeal/blood , Tuberculosis, Meningeal/cerebrospinal fluid , Tuberculosis, Meningeal/complications , Tuberculosis, Meningeal/epidemiologyABSTRACT
BACKGROUND: Disseminated cryptococcosis is a rare and fatal disease, and limited data exist regarding it in children. This study aimed to investigate the clinical characteristics of disseminated cryptococcosis in previously healthy children in China. METHODS: Hospitalized patients with disseminated cryptococcosis were enrolled during January 1996 to December 2015 in Beijing Children's Hospital, Capital Medical University, China. Data on clinical manifestations, laboratory tests, treatment, and prognosis were evaluated. RESULTS: A total of 52 pediatric patients with no underlying disease were enrolled, including 38 boys and 14 girls. Only 10 cases had a history of exposure to pigeon droppings. Fever, cough, and hepatomegaly were 3 main manifestations of disseminated cryptococcosis. However, headache was more common in patients with central nervous system (CNS) invasion than in patients with non-CNS invasion (P < 0.05). Lung (96.2%, 50/52) was the most commonly invaded organ, but only 9.6% (5/52) of patients had respiratory signs. The most common findings on chest imaging were hilar or mediastinal lymphadenopathy (46.8%, 22/47), and nodules (44.7%, 21/47), including small nodules in a scattered distribution (57.1%, 12/21) or miliary distribution (42.9%, 9/25), especially localized in subpleural area. Subsequent invasion occurred in the CNS, abdomen lymph nodes, liver, spleen, peripheral lymph nodes, and skin. In all patients, 42.3% (22/52) and 51.9% (27/52) had elevated eosinophils or IgE, respectively. The positive rate of serum cryptococcal antigen was higher, especially in patients with CNS invasion (approximately 83.3%), than with other primary methods used for pathogen detection, including cerebrospinal fluid (CSF) cryptococcal antigen, cultures of blood, bone marrow, or CSF, and CSF ink staining. The overall mortality rate of pediatric patients in our study was 11.5% (6/52). Some cases had long-term sequela, including hydrocephalus, cirrhosis, or blindness. CONCLUSIONS: Disseminated cryptococcosis can occur in previously healthy or immunocompetent children in China. Lung and CNS were most commonly invaded by this disease. Furthermore, most cases usually showed no obvious or specific symptoms or signs, and therefore pediatricians should pay more careful attention to identify this disease.
Subject(s)
Antifungal Agents/therapeutic use , Cryptococcosis/diagnosis , Cryptococcosis/etiology , Antigens, Fungal/blood , Child , Child, Preschool , China , Cough/microbiology , Cryptococcosis/drug therapy , Eosinophils/pathology , Female , Fever/microbiology , Headache/microbiology , Hepatomegaly/microbiology , Humans , Hydrocephalus/microbiology , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/microbiology , Lymph Nodes/pathology , Male , Prognosis , Radiography, Thoracic , Retrospective StudiesABSTRACT
We report an infant with hydrocephalus as the initial manifestation of Mycoplasma hominis-associated meningitis, who recovered without appropriate antimicrobial treatment. The analysis of the 16S rRNA gene by polymerase chain reaction amplification using universal primers and pathogen-specific primers was useful for the diagnosis and the investigation of serial detection status of the pathogen. This method may be helpful for the assessment of the frequency and the prediction of severity in M. hominis-associated central nervous system infection in infants, and investigating the association between M. hominis and the development of hydrocephalus.
Subject(s)
Hydrocephalus/microbiology , Meningitis/microbiology , Mycoplasma Infections/microbiology , Mycoplasma hominis/pathogenicity , Humans , Infant , MaleABSTRACT
Central nervous system tuberculosis (TB) is the most severe extra pulmonary TB having a high mortality and morbidity. OBJECTIVE: To study the various clinical, biochemical, and radiological spectrum of intracranial TB. MATERIALS AND METHOD: Ninety-three patients were enrolled in this prospective study after ethical clearance and consent from August 2013 to May 2015. The entire clinical course with complications and predictors of mortality were assessed. RESULTS: 36 females (38.7%) and 57 males (61.3%) were included whose mean age of presentation was 32.3±17.05 years. Alcohol was the most common risk factor seen in 19.4%. Headache (90.3%) was the most common symptom. Co-infection with human immunodeficiency virus, cryptococcal, and toxoplasmosis were seen in 11, 3, and 2 patients, respectively. Cerebrospinal fluid analysis showed acid-fast bacilli in 1 patient; polymerase chain reaction for TB and BACTEC was positive in one and three patients, respectively. Neuroimaging showed basal exudates (21.7%), tuberculoma (28.6%), brain edema (27%), hydrocephalus (32.9%), infarct (21%), and abscess (2.9%). Complications were noted such as brain edema (24.7%), vasculitis (26.9%), hydrocephalus (17.2%), hyponatremia (11.8%), drug-induced hepatitis (4.3%), and drug rash in 5 patients (5.4%). A total of 25 patients (26.9%) died and 38 patients (40.9%) developed neurological sequelae like hemiparesis, paraparesis, visual loss, and hearing loss. Logistic regression showed that a Glasgow scale of <10, British Medical Research Council stage 3, and vasculitis were associated with poor outcome. CONCLUSION: Lack of sensitive diagnostic method and criteria makes central nervous system TB a challenge where early diagnosis and prompt management is required.
Subject(s)
Brain Abscess/microbiology , Headache/microbiology , Tuberculoma, Intracranial/complications , Tuberculoma, Intracranial/diagnostic imaging , Tuberculosis, Meningeal/complications , Tuberculosis, Meningeal/diagnostic imaging , Adolescent , Adult , Aged , Brain Abscess/diagnostic imaging , Brain Edema/diagnostic imaging , Brain Edema/microbiology , Brain Infarction/diagnostic imaging , Brain Infarction/microbiology , Child , Child, Preschool , Coinfection , Female , Hearing Loss/microbiology , Hospitals , Humans , Hydrocephalus/diagnostic imaging , Hydrocephalus/microbiology , India , Male , Middle Aged , Neuroimaging , Paraparesis/microbiology , Risk Factors , Tomography, X-Ray Computed , Tuberculoma, Intracranial/cerebrospinal fluid , Tuberculosis, Meningeal/cerebrospinal fluid , Vision Disorders/microbiology , Young AdultABSTRACT
BACKGROUND: Tuberculosis is prevalent in China, which is the second greatest contributor to the global tuberculosis burden. Tuberculosis meningitis (TBM) is the most severe disease form but few reports describe long-term clinical outcomes and prognostic factors. Thus, we studied these features in Chinese TBM patients. METHODS: A retrospective follow-up study was used to collect clinical features and outcomes of adult TB meningitis at the First Affiliated Hospital of Chongqing Medical University from June 2012 to August 2015. Univariate analysis and multivariate analysis were used to identify predictive factors associated with outcomes at discharge and follow-up. RESULTS: TBM patients (N = 154) were a median age of 41 years (range: 16-82 years). Median time to follow-up was 26.4 months (range: 9.3-46.5 months) and 31% had poor outcomes at follow-up and limb weakness (p = 0.016), lower GCS scores (p < 0.001), cranial-nerve palsy (p = 0.024), and hydrocephalus (p = 0.009) were closely associated with these poor outcomes. Furthermore, a high neutrophil to lymphocytes ratio, high D-dimer, a low albumin to globulin ratio and slow background of EEG associated with poor outcomes as well. CONCLUSIONS: Mortality and disability associated with TBM are high in China. Limb weakness, GCS scores, cranial-nerve palsy and hydrocephalus were independent predictors of poor outcomes, and AGR, NLR, D-dimer, and EEG abnormalities may be prognostic factors of TBM.
Subject(s)
Antitubercular Agents/therapeutic use , Hydrocephalus/diagnosis , Mycobacterium tuberculosis/drug effects , Trochlear Nerve Diseases/diagnosis , Tuberculosis, Meningeal/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , China , Electrocorticography , Female , Fibrin Fibrinogen Degradation Products/metabolism , Follow-Up Studies , Humans , Hydrocephalus/drug therapy , Hydrocephalus/microbiology , Hydrocephalus/pathology , Lymphocytes/drug effects , Lymphocytes/immunology , Lymphocytes/microbiology , Male , Middle Aged , Multivariate Analysis , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/pathogenicity , Neutrophils/drug effects , Neutrophils/immunology , Neutrophils/microbiology , Prognosis , Retrospective Studies , Risk Factors , Serum Albumin/metabolism , Serum Globulins/metabolism , Trochlear Nerve Diseases/blood , Trochlear Nerve Diseases/drug therapy , Trochlear Nerve Diseases/pathology , Tuberculosis, Meningeal/drug therapy , Tuberculosis, Meningeal/microbiology , Tuberculosis, Meningeal/pathologyABSTRACT
BACKGROUND: Tuberculous meningitis in adults is well characterized in Vietnam, but there are no data on the disease in children. We present a prospective descriptive study of Vietnamese children with TBM to define the presentation, course and characteristics associated with poor outcome. METHODS: A prospective descriptive study of 100 consecutively admitted children with TBM at Pham Ngoc Thach Hospital, Ho Chi Minh City. Cox and logistic regression were used to identify factors associated with risk of death and a combined endpoint of death or disability at treatment completion. RESULTS: The study enrolled from October 2009 to March 2011. Median age was 32.5 months; sex distribution was equal. Median duration of symptoms was 18.5 days and time from admission to treatment initiation was 11 days. Fifteen of 100 children died, 4 were lost to follow-up, and 27/81 (33 %) of survivors had intermediate or severe disability upon treatment completion. Microbiological confirmation of disease was made in 6 %. Baseline characteristics associated with death included convulsions (HR 3.46, 95CI 1.19-10.13, p = 0.02), decreased consciousness (HR 22.9, 95CI 3.01-174.3, p < 0.001), focal neurological deficits (HR 15.7, 95CI 1.67-2075, p = 0.01), Blantyre Coma Score (HR 3.75, 95CI 0.99-14.2, p < 0.001) and CSF protein, lactate and glucose levels. Neck stiffness, MRC grade (children aged >5 years) and hydrocephalus were also associated with the combined endpoint of death or disability. CONCLUSIONS: Tuberculous meningitis in Vietnamese children has significant mortality and morbidity. There is significant delay in diagnosis; interventions that increase the speed of diagnosis and treatment initiation are likely to improve outcomes.